BMC Infect Dis. 2019 Jan 14;19(1):49. doi: 10.1186/s12879-019-3673-4.
Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed Western Region in China---case report and review of the literature.
Zhang YR1, Wu DM2, Liu XC2, Zhou N3, Cao CC4, Liu WH5, Wang CX6, Wang H3.
Author information
1
Department of Infectious diseases, The First People's Hospital of Lanzhou, No. 1 of Wu jia yuan West Street, Qilihe District, Lanzhou, 730050, Gansu, China. [email protected].
2
Department of Gastroenterology, The First People's Hospital of Lanzhou, Gansu, 730050, China.
3
Department of Infectious diseases, The First People's Hospital of Lanzhou, No. 1 of Wu jia yuan West Street, Qilihe District, Lanzhou, 730050, Gansu, China.
4
Department of Radiology, The First People's Hospital of Lanzhou, Gansu, 730050, China.
5
Department of general surgery, The First People's Hospital of Lanzhou, Gansu, 730050, China.
6
Department of laboratory, The First People's Hospital of Lanzhou, Gansu, 730050, China.
Abstract
BACKGROUND:
For patients with chronic hepatitis B and cirrhosis in less developed western regions in China, due to constraints of local economic conditions, the choice of treatment measures is often limited. However if patients recieved valid management and effective treatment, they were able to maintain their health and benign prognosis.
CASE PRESENTATION:
This study narrates the long-term treatment and careful follow-up of a patient with chronic hepatitis B and cirrhosis in a less developed western region in China, and analyzes the prognosis of the disease and countermeasures.
CONCLUSIONS:
This would partly reflect the development of antiviral therapy for chronic hepatitis B and multidisciplinary comprehensive treatment for cirrhosis-related complications in remote region with limited resources in the past 20 years.
KEYWORDS: